从纤维架构到功能附件:一个临床相关的,机械调节的心脏补丁
Johannes Braig1, Ross Kent2, Ainitze Gereka Goienetxe2,3
1Department of Functional Materials in Medicine and Dentistry, Institute of Biofabrication and Functional Materials, University of Würzburg and KeyLab Polymers For Medicine of the Bavarian Polymer Institute (BPI), Würzburg, Germany.
Advanced materials (Deerfield Beach, Fla.)
|February 20, 2026
概括
作为生物心室辅助装置 (BioVADs) 的工程心脏贴片被优化为心肌梗塞治疗. 这种新的设计增强了机械支,促进了细胞对齐,并确保了安全的附着,以改善心脏功能.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 心血管工程 心血管工程
背景情况:
- 工程心脏贴片显示为心肌梗塞治疗作为生物心室辅助装置 (BioVADs) 的承诺.
- 最佳的贴片设计和附着对于受损心脏的机械支持至关重要,但仍然未被充分探索.
- 目前的方法缺乏个性化的机械特性和强大的整合策略.
研究的目的:
- 开发和验证一个个性化,多区域工程心脏贴片平台用于心肌梗塞治疗.
- 为了研究脚手架微型架构和机械特性之间的相互作用,以获得最佳的心脏支持.
- 在临床前心肌梗塞模型中评估设计的BioVAD的疗效.
主要方法:
- 计算建模用于设计多区域微型架构 (再生,力传输,附着区域).
- 使用定制G码生成器进行融电写 (MEW) 制造.
- 数字图像相关性和双轴测试以描述脚手架机制和区域应变差异.
- 脊心留测试和动态BioVAD培养与心肌细胞.
- 在猪心肌梗塞模型中的体内评估.
主要成果:
- 脚手架表现出明显的区域力学,压力差异高达2.6倍,模仿本地心肌直至10%的压力.
- 一个加强的轮提高了2.16倍的接保持力,使接的形状可以改变.
- 动态培养显著增强心肌细胞对齐 (p = 0.01).
- 在体内,BioVAD在7天内实现了完全的上心附着和血管内生长.
结论:
- 融电写是一种多功能平台,可以创建个性化的心脏支架,具有量身定制的机械性能.
- 开发的多区域BioVAD平台有效支持肌肉梗塞后的组织整合和心脏功能.
- 这种方法为开发下一代心脏再生疗法提供了一个有希望的策略.
相关概念视频
01:16Heart Valves
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...